(Q42987580)

12 November 2017

title

Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

4

1 reference

12 November 2017

Hermann E Wasmuth

1

1 reference

12 November 2017

Alexa Werth

2

1 reference

12 November 2017

Tobias Mueller

3

1 reference

12 November 2017

Christoph G Dietrich

5

1 reference

12 November 2017

Andreas Geier

6

1 reference

12 November 2017

Carsten Gartung

7

1 reference

12 November 2017

Johann Lorenzen

8

1 reference

12 November 2017

Siegfried Matern

9

1 reference

12 November 2017

Frank Lammert

10

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

12 November 2017

1 reference

12 November 2017

volume

40

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

327-334

1 reference

Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C.

12 November 2017

cites work

1 reference

Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES.

21 January 2018

1 reference

Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders?

21 January 2018

1 reference

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

7 January 2021

Chemokines and disease

1 reference

7 January 2021

Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease

1 reference

7 January 2021

Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES.

1 reference

7 January 2021

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

1 reference

7 January 2021

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.

1 reference

7 January 2021

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

7 January 2021

Immunological predictors of different responses to combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C.

1 reference

7 January 2021

Modulating influence on HIV/AIDS by interacting RANTES gene variants

1 reference

7 January 2021

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression

1 reference

7 January 2021

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

1 reference

7 January 2021

From genotypes to haplotypes in hepatobiliary diseases: one plus one equals (sometimes) more than two.

1 reference

7 January 2021

A New Statistical Method for Haplotype Reconstruction from Population Data

1 reference

7 January 2021

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

1 reference

7 January 2021

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

7 January 2021

CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia

1 reference

7 January 2021

Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay

1 reference

7 January 2021

Case-control studies: research in reverse

1 reference

7 January 2021

The complex interplay among factors that influence allelic association.

1 reference

7 January 2021

Finding genes underlying risk of complex disease by linkage disequilibrium mapping

1 reference

7 January 2021

A comparison of bayesian methods for haplotype reconstruction from population genotype data

1 reference

7 January 2021

A note on the calculation of empirical P values from Monte Carlo procedures.

1 reference

7 January 2021

Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases

1 reference

7 January 2021

Host factors and failure of interferon-alpha treatment in hepatitis C virus

1 reference

7 January 2021

C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.

1 reference

7 January 2021

The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin.

1 reference

7 January 2021

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

1 reference

7 January 2021

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

1 reference

7 January 2021

Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy

1 reference

7 January 2021

Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.

1 reference

7 January 2021

Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin.

1 reference

7 January 2021

Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL.

1 reference

7 January 2021

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

1 reference

7 January 2021

A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C.

1 reference

7 January 2021

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

1 reference

7 January 2021

Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal

1 reference

7 January 2021

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

1 reference

7 January 2021

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits

1 reference

7 January 2021

Haplotype variation and linkage disequilibrium in 313 human genes

1 reference

7 January 2021

The International HapMap Project

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20322

1 reference

12 November 2017

1 reference